Lung cancer is the second most common cancer and the leading cause of cancer-related
death worldwide. Molecular imaging using [18 F] fluorodeoxyglucose Positron Emission …

In the last hundred years, lung cancer has risen from a reportable disease to the most
common cause of death from cancer in both men and women in developed countries (1) …

Purpose To determine the non-therapeutic thymectomy rate in a recent six-year consecutive
thymectomy cohort, the etiology of these unnecessary thymectomies, and the differentiating …

Background Lung cancer is one of the leading causes of cancer-related deaths worldwide.
Accurate staging is important for patient management and clinical research. The recognition …

Purpose To evaluate the association of pleural tags with visceral pleural invasion of non–
small cell lung cancer (NSCLC) that does not abut the pleural surface. Materials and …

Purpose To compare the quantitative and qualitative lung perfusion data acquired with dual
energy CT (DECT) to that acquired with a large field-of-view cadmium-zinc-telluride camera …

Background Bevacizumab is a monoclonal antibody against vascular endothelial growth
factor. Severe pulmonary haemorrhage (PH) is a rare but serious potential adverse event …

With a high rise in deaths caused due to novel coronavirus (nCoV), immunocompromised
persons are at high risk. Lung cancer is no exception. Classifying lung cancer patients and …

Purpose The recommended treatment for small-cell lung cancer (SCLC) currently is surgery
in stage I disease. We wondered about stage II SCLC and present a meta-analysis on mean …

This review summarizes the current literature and tries to define the status of nuclear
medicine in the clinical workup of lung cancer patients. Nuclear medicine procedures and …